CLINICAL TRIALS PROFILE FOR VASOSTRICT
✉ Email this page to a colleague
All Clinical Trials for VASOSTRICT
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02975999 ↗ | Use of Vasopressin Following the Fontan Operation | Suspended | Advocate Health Care | Phase 2/Phase 3 | 2016-12-01 | The purpose of this study is to determine whether Vasopressin following the Fontan operation will decrease chest tube output and duration. |
| NCT04093050 ↗ | Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers | Completed | Endo Pharmaceuticals | Phase 1 | 2019-10-10 | Open-label Phase I pharmacokinetic (PK) study of Vasostrict® (vasopressin injection, USP) in healthy volunteers. |
| NCT05193370 ↗ | Pilot RCT of Angiotensin II vs. Vasopressin in Septic Shock | Not yet recruiting | La Jolla Pharmaceutical Company | Phase 4 | 2022-01-03 | This will be a randomized controlled unblinded pragmatic single-center pilot trial of the use of vasopressin vs. angiotensin II as a second-line vasopressor in patients with septic shock and persistent hypotension despite moderate-to-high doses of norepinephrine. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VASOSTRICT
Condition Name
Clinical Trial Locations for VASOSTRICT
Trials by Country
Clinical Trial Progress for VASOSTRICT
Clinical Trial Phase
Clinical Trial Sponsors for VASOSTRICT
Sponsor Name
